CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Advanz Pharma Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Advanz Pharma Corp
5770 Hurontario St Suite 310
Phone: (905) 842-5150p:905 842-5150 MISSISSAUGA, ON  L5R 3G5  Canada Ticker: ADVZADVZ

Business Summary
Advanz Pharma Corp, formerly Concordia International Corp, is a Canada-based pharmaceutical company. It is an international specialty pharmaceutical company with a diversified portfolio of more than 200 patented and off-patent products, and sales in more than 90 countries. The Company is focused on investing in product portfolio with aim to optimize healthcare treatment. The Company does this through product acquisitions, in-licensing opportunities, product development and alliances worldwide. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products and operates facilities in various locations, including Bridgetown, Barbados; London, England; Mumbai, India, and Mississauga, Canada.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201912/31/2018YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Independent Chairman of the Board RandallBenson 59 5/28/2018 5/28/2018
Chief Executive Officer, Director GraemeDuncan 45 5/2/2018 5/2/2018
Chief Financial Officer AdeelAhmad 45 6/1/2018 6/1/2018
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
ADVANZ PHARMA CORP.
CONCORDIA INTERNATIONAL CORP.

Business Names
Business Name
Abcur AB
Abcur AB
ADVZ
38 additional Business Names available in full report.

General Information
Number of Employees: 435 (As of 12/31/2018)
Outstanding Shares: 48,913,490 (As of 9/30/2019)
Stock Exchange: TSE
Fax Number: (905) 842-5154


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 10, 2019